PPC you need to look at the rights issue, how much dilution is there on there NAV.
PPC’s FUNDING STRATEGY
The Board and the Executive Management of the Company have reviewed
the Company’s business plan and capital structure and are in the
process of implementing a funding strategy which incorporates a
capital raise to deal effectively with the impact of a continued
low-growth environment as well as the potential redemption of the
Notes and the strengthening of the balance sheet.
The Company intends to raise between R3 billion and R4 billion in
gross proceeds through a rights issue. PPC is in discussions with
various parties with respect to the potential underwriting of the
proposed rights issue. The Company will also consider such other
forms of equity capital raising as may be appropriate in light of
its position, market conditions and other factors.
The Board intends to announce further details regarding the proposed
rights issue on 14 June 2016, when it releases its results for the
financial year ended 31 March 2016, and to publish a shareholder
circular convening an extraordinary general meeting to approve the
required shareholder resolutions in order to implement the proposed
rights issue on or about 28 June 2016.
In the interim, and in order to address its commitments to the
noteholders, the Company has executed a credit approved term sheet
with its debt providers which summarises the terms and conditions on
which such debt providers will step in as guarantors to the
noteholders.
FURTHER CAUTIONARY ANNOUNCEMENT
Further to the cautionary announcement released on 23 May 2016 and
the information set out in this announcement, security holders are
advised to continue exercising caution when dealing in PPC
securities until a further announcement is published.
Any securities which will be offered will not be and have not been
registered under the US Securities Act of 1933 (“US Securities Act”)
and may not be offered or sold in the United States absent
registration or an applicable exemption from the registration
requirements under the US Securities Act.